Literature DB >> 22926168

Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease.

Stefanie Reyes1, Yuhong Fu, Kay L Double, Veronica Cottam, Lachlan H Thompson, Deniz Kirik, George Paxinos, Charles Watson, Helen M Cooper, Glenda M Halliday.   

Abstract

Recent studies suggest a variety of factors characterize substantia nigra neurons vulnerable to Parkinson's disease, including the transcription factors pituitary homeobox 3 (Pitx3) and orthodenticle homeobox 2 (Otx2) and the trophic factor receptor deleted in colorectal cancer (DCC), but there is limited information on their expression and localization in adult humans. Pitx3, Otx2, and DCC were immunohistochemically localized in the upper brainstem of adult humans and mice and protein expression assessed using relative intensity measures and online microarray data. Pitx3 was present and highly expressed in most dopamine neurons. Surprisingly, in our elderly subjects no Otx2 immunoreactivity was detected in dopamine neurons, although Otx2 gene expression was found in younger cases. Enhanced DCC gene expression occurred in the substantia nigra, and higher amounts of DCC protein characterized vulnerable ventral nigral dopamine neurons. Our data show that, at the age when Parkinson's disease typically occurs, there are no significant differences in the expression of transcription factors in brainstem dopamine neurons, but those most vulnerable to Parkinson's disease rely more on the trophic factor receptor DCC than other brainstem dopamine neurons.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926168     DOI: 10.1016/j.neurobiolaging.2012.07.019

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  18 in total

Review 1.  The Netrin-1/DCC Guidance Cue Pathway as a Molecular Target in Depression: Translational Evidence.

Authors:  Angélica Torres-Berrío; Giovanni Hernandez; Eric J Nestler; Cecilia Flores
Journal:  Biol Psychiatry       Date:  2020-05-11       Impact factor: 13.382

2.  Amphetamine in adolescence disrupts the development of medial prefrontal cortex dopamine connectivity in a DCC-dependent manner.

Authors:  Lauren M Reynolds; Carolina S Makowski; Sandra V Yogendran; Silke Kiessling; Nicolas Cermakian; Cecilia Flores
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

Review 3.  Graphene-Based Electrochemical Sensors for Psychoactive Drugs.

Authors:  Ramin Boroujerdi; Richard Paul
Journal:  Nanomaterials (Basel)       Date:  2022-06-30       Impact factor: 5.719

4.  DCC Receptors Drive Prefrontal Cortex Maturation by Determining Dopamine Axon Targeting in Adolescence.

Authors:  Lauren M Reynolds; Matthew Pokinko; Angélica Torres-Berrío; Santiago Cuesta; Laura C Lambert; Esther Del Cid Pellitero; Michael Wodzinski; Colleen Manitt; Paul Krimpenfort; Bryan Kolb; Cecilia Flores
Journal:  Biol Psychiatry       Date:  2017-06-16       Impact factor: 13.382

5.  Netrin1 deficiency activates MST1 via UNC5B receptor, promoting dopaminergic apoptosis in Parkinson's disease.

Authors:  Eun Hee Ahn; Seong Su Kang; Qi Qi; Xia Liu; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-14       Impact factor: 11.205

Review 6.  Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.

Authors:  Angela Anderegg; Jean-Francois Poulin; Rajeshwar Awatramani
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

7.  Mesocorticolimbic Connectivity and Volumetric Alterations in DCC Mutation Carriers.

Authors:  Daniel E Vosberg; Yu Zhang; Aurore Menegaux; Amanda Chalupa; Colleen Manitt; Simone Zehntner; Conrad Eng; Kristina DeDuck; Dominique Allard; France Durand; Alain Dagher; Chawki Benkelfat; Myriam Srour; Ridha Joober; Franco Lepore; Guy Rouleau; Hugo Théoret; Barry J Bedell; Cecilia Flores; Marco Leyton
Journal:  J Neurosci       Date:  2018-04-30       Impact factor: 6.167

Review 8.  Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update.

Authors:  Lars Brichta; Paul Greengard
Journal:  Front Neuroanat       Date:  2014-12-15       Impact factor: 3.856

Review 9.  Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease.

Authors:  Allen P F Chen; Lu Chen; Thomas A Kim; Qiaojie Xiong
Journal:  Biomedicines       Date:  2021-06-07

Review 10.  Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease.

Authors:  Daniela Maria Vogt Weisenhorn; Florian Giesert; Wolfgang Wurst
Journal:  J Neurochem       Date:  2016-06-27       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.